Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH
SAN ANTONIO – Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease...
Search/Filter
Loading...
Circulating Tumor Cell Count Could Help Choose Treatment for Metastatic Breast Cancer Patients
SAN ANTONIO – Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment...
Delaying Adjuvant Chemotherapy Associated With Worse Outcomes for Patients With Triple-negative Breast Cancer
“SAN ANTONIO – Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after...
Adjuvant Chemotherapy Might Not Add Benefit in Breast Cancer Patients who Have Excellent Response to Neoadjuvant Chemotherapy
“SAN ANTONIO – Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and...
Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Adjuvant Capecitabine Did Not Significantly Improve Outcomes for Patients With Early-stage Triple-negative Breast Cancer
Subgroup analysis suggested the treatment may benefit patients with nonbasal-like disease SAN ANTONIO Treating patients who had early-stage triple-negative...
Tailored Lifestyle Feedback Given During Colorectal Cancer Screening Improved Patients’ Health Behaviors
PHILADELPHIA – A program that provided individually tailored lifestyle recommendations for patients undergoing screening for colorectal cancer helped encourage...
AACR Mourns the Loss of George H.W. Bush, the 41st President of the United States
On behalf of the Board of Directors of the American Association for Cancer Research (AACR), and the 40,000 laboratory...
The Pancreatic Cancer Collective Awards $7 Million in First-round “New Therapies Challenge” Grants
“The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded...
Many Patients Diagnosed with High-risk Adenomas May Not Receive Subsequent Colonoscopies in Recommended Time Frame
PHILADELPHIA – Patients who are diagnosed with adenomas, a possible precursor of colorectal cancer, often do not receive subsequent...